J&J's Simponi Fails to Receive U.S. FDA Clearance for Wider utilization San Francisco Chronicle The company said it would request a meeting with the Food and Drug Administration to discuss what would be required to gain approval for the drug as a method of curbing the series of joint damage from the type of arthritis linked to psoriasis , ... Dr. Alexander Shikhman to educate the in the public eye on psoriatic arthritis for the ... MMD Newswire (press release) all ii news articles » Link To Article
No comments:
Post a Comment